• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际儿童哮喘和过敏研究(ISAAC)与欧洲共同体呼吸健康调查(ECRHS)中哮喘患病率的比较。ISAAC指导委员会和欧洲共同体呼吸健康调查。国际儿童哮喘和过敏研究。

Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood.

作者信息

Pearce N, Sunyer J, Cheng S, Chinn S, Björkstén B, Burr M, Keil U, Anderson H R, Burney P

机构信息

Wellington Asthma Research Group, Wellington School of Medicine, New Zealand.

出版信息

Eur Respir J. 2000 Sep;16(3):420-6. doi: 10.1183/9031936.00.16337700.

DOI:10.1183/9031936.00.16337700
PMID:11028654
Abstract

International and regional prevalence comparisons are required to test and generate hypotheses regarding the causes of increasing asthma prevalence in various age groups worldwide. The International Study of Asthma and Allergies in Childhood (ISAAC) is the first such study in children and the European Community Respiratory Health Survey (ECRHS) is the first such study in adults. Therefore, a comparison of the findings of these two surveys was conducted, for the 17 countries in which both surveys were undertaken. There was a strong correlation between the ISAAC and ECRHS prevalence data, with 64% of the variation at the country level, and 74% of the variation at the centre level, in the prevalence of "wheeze in the last 12 months" in the ECRHS phase I data being explained by the variation in the ISAAC phase I data. There was also generally good agreement in the international patterns observed in the two surveys for self-reported asthma (74% of country level and 36% of centre level variation explained), self-reported asthma before age 14 yrs (64 and 26%), hay fever (61 and 73%) and eczema (41 and 50%). Thus although there were differences in the absolute levels of prevalence observed in the two surveys, there is good overall agreement between the International Study of Asthma and Allergies in Childhood and European Community Respiratory Health Survey study findings with regard to international prevalence patterns. These findings, therefore, add support to the validity of the two studies, which provide a new picture of global patterns of asthma prevalence from child- to adulthood, and identify some of the key phenomena which future research must address.

摘要

需要进行国际和区域患病率比较,以检验并提出关于全球各年龄组哮喘患病率上升原因的假设。“儿童哮喘和过敏国际研究”(ISAAC)是此类针对儿童的首次研究,“欧洲共同体呼吸健康调查”(ECRHS)是此类针对成人的首次研究。因此,对这两项调查均开展的17个国家的调查结果进行了比较。ISAAC和ECRHS的患病率数据之间存在很强的相关性,ECRHS第一阶段数据中“过去12个月喘息”患病率在国家层面64%的变化以及在中心层面74%的变化可由ISAAC第一阶段数据的变化来解释。在两项调查中观察到的自我报告哮喘(国家层面74%和中心层面36%的变化得到解释)、14岁前自我报告哮喘(64%和26%)、花粉症(61%和73%)以及湿疹(41%和50%)的国际模式也总体上具有良好的一致性。因此,尽管两项调查中观察到的患病率绝对水平存在差异,但“儿童哮喘和过敏国际研究”与“欧洲共同体呼吸健康调查”在国际患病率模式方面的研究结果总体上具有良好的一致性。因此,这些发现为两项研究的有效性提供了支持,这两项研究呈现了从儿童到成人的哮喘患病率全球模式的新情况,并确定了一些未来研究必须解决的关键现象。

相似文献

1
Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood.国际儿童哮喘和过敏研究(ISAAC)与欧洲共同体呼吸健康调查(ECRHS)中哮喘患病率的比较。ISAAC指导委员会和欧洲共同体呼吸健康调查。国际儿童哮喘和过敏研究。
Eur Respir J. 2000 Sep;16(3):420-6. doi: 10.1183/9031936.00.16337700.
2
[Prevalence of symptoms of asthma, allergic rhinitis, conjunctivitis and atopic eczema: ISAAC (International Study of Asthma and Allergies in Childhood) in a population of schoolchildren in Zagreb].[哮喘、过敏性鼻炎、结膜炎和特应性皮炎症状的患病率:萨格勒布学童群体中的儿童哮喘和过敏国际研究(ISAAC)]
Acta Med Croatica. 2003;57(4):281-5.
3
ISAAC-based asthma and atopic symptoms among Ha Noi school children.河内学童中基于国际哮喘及变应性疾病研究(ISAAC)的哮喘和特应性症状
Pediatr Allergy Immunol. 2003 Aug;14(4):272-9. doi: 10.1034/j.1399-3038.2003.00043.x.
4
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.哮喘、过敏性鼻结膜炎和特应性皮炎症状患病率的全球差异:国际儿童哮喘和过敏研究(ISAAC)。国际儿童哮喘和过敏研究(ISAAC)指导委员会。
Lancet. 1998 Apr 25;351(9111):1225-32.
5
Asthma, hay fever and eczema in Irish teenagers (ISAAC protocol).爱尔兰青少年的哮喘、花粉热和湿疹(国际儿童哮喘和过敏研究协会方案)
Ir Med J. 1997 Apr-May;90(3):110-2.
6
Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires.使用国际儿童哮喘和过敏研究(ISAAC)问卷对曼谷地区儿童哮喘、鼻炎和湿疹的患病率进行调查。
J Med Assoc Thai. 1998 Mar;81(3):175-84.
7
Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old children in Kuwait: an ISAAC study. International Study of Asthma and Allergies in Childhood.科威特13至14岁儿童哮喘、过敏性鼻炎和湿疹的患病率:一项儿童哮喘和过敏国际研究(ISAAC研究)
Ann Allergy Asthma Immunol. 2000 Jul;85(1):58-63. doi: 10.1016/s1081-1206(10)62435-0.
8
Prevalence of childhood asthma and allergies in Serbia and Montenegro.塞尔维亚和黑山儿童哮喘和过敏的流行情况。
World J Pediatr. 2010 Nov;6(4):331-6. doi: 10.1007/s12519-010-0207-y. Epub 2010 Jun 12.
9
Time trends of the prevalence of asthma and allergic disease in Austrian children.奥地利儿童哮喘和过敏性疾病患病率的时间趋势。
Pediatr Allergy Immunol. 2008 Mar;19(2):125-31. doi: 10.1111/j.1399-3038.2007.00597.x. Epub 2007 Dec 14.
10
[European Community Respiratory Health Survey in Adults (ECRHS)].[欧洲成人呼吸健康调查(ECRHS)]
Pneumologie. 2002 May;56(5):297-303. doi: 10.1055/s-2002-30699.

引用本文的文献

1
Special Issue "Molecular Mechanisms and Treatment of Allergic Reactions".特刊“过敏反应的分子机制与治疗”。
Int J Mol Sci. 2025 Aug 1;26(15):7461. doi: 10.3390/ijms26157461.
2
Assessing spirometry, exhaled nitric oxide, and asthma symptoms score as instruments for respiratory health evaluation among women in a low socioeconomic context: a cross-sectional study.评估肺量计、呼出一氧化氮和哮喘症状评分作为低社会经济背景下女性呼吸健康评估工具的研究:一项横断面研究
BMC Public Health. 2025 Jun 5;25(1):2095. doi: 10.1186/s12889-025-23324-9.
3
A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database.
一项在FDA不良药物事件报告系统数据库中使用不成比例分析的奥马珠单抗真实世界药物警戒研究。
Sci Rep. 2025 Mar 7;15(1):8045. doi: 10.1038/s41598-025-91463-5.
4
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.过敏与自身免疫之间的临床及病理生理纠葛:解构旧有的二分法范式
Clin Rev Allergy Immunol. 2025 Feb 11;68(1):13. doi: 10.1007/s12016-024-09020-3.
5
Global, regional, and national epidemiology of allergic diseases in children from 1990 to 2021: findings from the Global Burden of Disease Study 2021.1990年至2021年全球儿童过敏性疾病的全球、区域和国家流行病学:2021年全球疾病负担研究的结果
BMC Pulm Med. 2025 Jan 31;25(1):54. doi: 10.1186/s12890-025-03518-y.
6
Early family socioeconomic status and asthma-related outcomes in school-aged children: Results from seven birth cohort studies.学龄儿童早期家庭社会经济地位与哮喘相关结局:七项出生队列研究的结果
J Epidemiol Community Health. 2024 Dec 10;79(1):1-11. doi: 10.1136/jech-2023-220726.
7
Global, regional and national epidemiology of allergic disorders in children from 1990 to 2019: findings from the Global Burden of Disease study 2019.全球、区域和国家儿童过敏疾病流行病学:2019 年全球疾病负担研究的发现。
BMJ Open. 2024 Apr 8;14(4):e080612. doi: 10.1136/bmjopen-2023-080612.
8
Asthma, Airflow Obstruction, and Eosinophilic Airway Inflammation Prevalence in Western Kenya: A Population-Based Cross-Sectional Study.肯尼亚西部的哮喘、气流阻塞和嗜酸性气道炎症的流行情况:一项基于人群的横断面研究。
Int J Public Health. 2023 Aug 17;68:1606030. doi: 10.3389/ijph.2023.1606030. eCollection 2023.
9
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.全球、地区和国家的过敏疾病负担及其风险因素:2019 年全球疾病负担研究 1990-2019 年系统性分析。
Allergy. 2023 Aug;78(8):2232-2254. doi: 10.1111/all.15807. Epub 2023 Jul 11.
10
Why has epidemiology not (yet) succeeded in identifying the origin of the asthma epidemic?为什么流行病学尚未成功确定哮喘流行的起源?
Int J Epidemiol. 2023 Aug 2;52(4):974-983. doi: 10.1093/ije/dyad035.